Clinical Trials Browser

Not yet recruiting × OTHER × zimberelimab × Clear all

NCT07424664 2026-02-20

A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence, Vaginal Neoplasms, Vulvar Neoplasms

NCT07397611 2026-02-09

Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC

Phase 2 Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07337447 2026-01-13

REWENEC 01

Phase 2 Not yet recruiting

Carcinoma, Neuroendocrine

NCT06528483 2024-07-30

preSAVE

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

NCT06166589 2023-12-12

Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06128460 2023-11-30

Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT06009029 2023-08-24

SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)

Phase 2 Not yet recruiting

Gastrointestinal

Locally Advanced Pancreatic Cancer